Lv21
120 积分 2022-07-05 加入
Safety and efficacy of immune checkpoint inhibitors after allogeneic hematopoietic cell transplantation
3小时前
待确认
CD8+ T-cell Differentiation and Dysfunction Inform Treatment Response in Acute Myeloid Leukemia
1个月前
已完结
CD8+ T-cell Differentiation and Dysfunction Inform Treatment Response in Acute Myeloid Leukemia
1个月前
已关闭
Consensus on the monitoring, treatment, and prevention of leukaemia relapse after allogeneic haematopoietic stem cell transplantation in China: 2024 update
1个月前
已完结
HIF-1α can act as a tumor suppressor gene in murine acute myeloid leukemia
1个月前
已完结
HIF-1α can act as a tumor suppressor gene in murine acute myeloid leukemia
1个月前
已关闭
CD200 + cytotoxic T lymphocytes in the tumor microenvironment are crucial for efficacious anti–PD-1/PD-L1 therapy
1个月前
已完结
Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults
4个月前
已完结
Mini-hyper-CVD plus inotuzumab ozogamicin, with or without blinatumomab, in the subgroup of older patients with newly diagnosed Philadelphia chromosome-negative B-cell acute lymphocytic leukaemia: long-term results of an open-label phase 2 trial
4个月前
已完结
Inotuzumab Ozogamicin as Induction Therapy for Patients Older Than 55 Years With Philadelphia Chromosome–Negative B-Precursor ALL
4个月前
已完结
皖公网安备34019202002308
